TY - JOUR
T1 - 2019 Endocrine society measures set for older adults with type 2 diabetes who are at risk for hypoglycemia
T2 - Performance measures for eligible clinicians developed by the endocrine society
AU - Rosenzweig, James L.
AU - Conlin, Paul R.
AU - Gonzalvo, Jasmine D.
AU - Kutler, Stephanie B.
AU - Maruthur, Nisa M.
AU - Solis, Penelope
AU - Vijan, Sandeep
AU - Wallia, Amisha
AU - Wright, Robin Fein
N1 - Funding Information:
The Hypoglycemia Prevention Initiative and all related activities are supported by Abbott Diabetes Care Inc., Lilly USA, LLC, Merck & Co., Inc., Novo Nordisk Inc., and Sanofi.
Publisher Copyright:
© Endocrine Society 2019. All rights reserved.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Context: Hypoglycemia in the outpatient setting has a significant financial impact on the health care system and negative impact on a person's quality of life. Primary care physicians must address a multitude of issues in a visit with a person with type 2 diabetes mellitus (T2DM), often leaving little time to ask about hypoglycemia. Objective: To develop quality measures that focus on outpatient hypoglycemia episodes for patients 65 and older with T2DM, which facilitate a clinician's ability to identify opportunities to improve the quality of care and reduce hypoglycemic episodes. Participants and Process: A technical expert panel established by the Endocrine Society in March 2019, which includes endocrinologists, primary care physicians, a diabetes care and education specialist/pharmacist, and a patient, developed 3 outpatient hypoglycemia quality measures. The measure set is intended to improve quality of care for patients with T2DM who are at greatest risk for hypoglycemia. The measures were available for public comment in July 2019. A fourth measure on shared decision-making was removed from the final measure set based on public feedback. Conclusion: A lack of outpatient hypoglycemia measures focusing on older adults with T2DM is a barrier to improving care of people with diabetes and reducing hypoglycemic episodes. This paper provides measure specifications for 3 measures that may be used to focus quality improvement efforts on patients at greatest risk for hypoglycemia.
AB - Context: Hypoglycemia in the outpatient setting has a significant financial impact on the health care system and negative impact on a person's quality of life. Primary care physicians must address a multitude of issues in a visit with a person with type 2 diabetes mellitus (T2DM), often leaving little time to ask about hypoglycemia. Objective: To develop quality measures that focus on outpatient hypoglycemia episodes for patients 65 and older with T2DM, which facilitate a clinician's ability to identify opportunities to improve the quality of care and reduce hypoglycemic episodes. Participants and Process: A technical expert panel established by the Endocrine Society in March 2019, which includes endocrinologists, primary care physicians, a diabetes care and education specialist/pharmacist, and a patient, developed 3 outpatient hypoglycemia quality measures. The measure set is intended to improve quality of care for patients with T2DM who are at greatest risk for hypoglycemia. The measures were available for public comment in July 2019. A fourth measure on shared decision-making was removed from the final measure set based on public feedback. Conclusion: A lack of outpatient hypoglycemia measures focusing on older adults with T2DM is a barrier to improving care of people with diabetes and reducing hypoglycemic episodes. This paper provides measure specifications for 3 measures that may be used to focus quality improvement efforts on patients at greatest risk for hypoglycemia.
KW - Diabetes
KW - Diabetes medications
KW - Hypoglycemia
KW - Older adults
KW - Performance measures
KW - Quality improvement
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85082096679&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082096679&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgz250
DO - 10.1210/clinem/dgz250
M3 - Article
C2 - 31825487
AN - SCOPUS:85082096679
VL - 105
SP - 969
EP - 990
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 4
ER -